Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	amino acid:sodium symporter activity	SLC38A4 SLC6A15 SLC6A6 SLC6A11	2.49e-05	23	151	4	GO:0005283
GeneOntologyMolecularFunction	amino acid:monoatomic cation symporter activity	SLC38A4 SLC6A15 SLC6A6 SLC6A11	6.44e-05	29	151	4	GO:0005416
GeneOntologyMolecularFunction	organic acid:sodium symporter activity	SLC38A4 SLC6A15 SLC6A6 SLC6A11	1.37e-04	35	151	4	GO:0005343
GeneOntologyMolecularFunction	taurine:sodium symporter activity	SLC6A6 SLC6A11	1.70e-04	3	151	2	GO:0005369
GeneOntologyMolecularFunction	collagen fibril binding	CHADL TNXB	1.70e-04	3	151	2	GO:0098633
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	TRPV1 TPCN2 RYR3	3.18e-04	18	151	3	GO:0015278
GeneOntologyMolecularFunction	calcium channel activity	TRPV1 TPCN2 TRPC3 PKD1L3 RYR3 TRPM1	4.49e-04	129	151	6	GO:0005262
GeneOntologyMolecularFunction	taurine transmembrane transporter activity	SLC6A6 SLC6A11	5.60e-04	5	151	2	GO:0005368
GeneOntologyMolecularFunction	ligand-gated monoatomic cation channel activity	TRPV1 TPCN2 TRPC3 ANO10 RYR3 SCNN1B	6.91e-04	140	151	6	GO:0099094
GeneOntologyMolecularFunction	gamma-aminobutyric acid:sodium:chloride symporter activity	SLC6A6 SLC6A11	8.35e-04	6	151	2	GO:0005332
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	TRPV1 TPCN2 SLC38A4 TRPC3 SLC6A15 PKD1L3 RYR3 SLC6A6 SLC6A11 SCNN1B TRPM1	8.38e-04	465	151	11	GO:0046873
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	TRPV1 TPCN2 TRPC3 PKD1L3 RYR3 TRPM1	1.03e-03	151	151	6	GO:0015085
GeneOntologyBiologicalProcess	calcium ion transmembrane import into cytosol	AKAP6 TRPV1 TPCN2 GIMAP5 ERO1A TRPC3 RYR3 CD19 TRPM1 OGA	4.94e-06	217	152	10	GO:0097553
Pathway	REACTOME_STIMULI_SENSING_CHANNELS	TRPV1 TPCN2 TRPC3 ANO10 RYR3 CLCN1 SCNN1B TRPM1	1.42e-06	99	115	8	MM14910
Pathway	REACTOME_STIMULI_SENSING_CHANNELS	TRPV1 TPCN2 TRPC3 ANO10 RYR3 CLCN1 SCNN1B TRPM1	2.38e-06	106	115	8	M27200
Pathway	REACTOME_DIGESTION_AND_ABSORPTION	SI LCT NPC1L1 ALPP	4.66e-05	25	115	4	MM15557
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	TRPV1 TPCN2 TRPC3 ANO10 RYR3 CLCN1 SCNN1B TRPM1	9.57e-05	176	115	8	MM15718
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	TRPV1 TPCN2 TRPC3 ANO10 RYR3 CLCN1 SCNN1B TRPM1	1.25e-04	183	115	8	M997
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	TRPV1 SLC29A3 CYB5RL TPCN2 SLC38A4 TRPC3 PSMB4 IREB2 SLC6A15 ANO10 RYR3 SLC6A6 SLC6A11 CLCN1 SCNN1B TRPM1	1.27e-04	681	115	16	MM14985
Pubmed	An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis.	CYP21A2 TNXA TNXB	8.85e-08	3	156	3	10343159
Pubmed	An unequal crossover event in RCCX modules of the human MHC resulting in the formation of a TNXB/TNXA hybrid and deletion of the CYP21A.	CYP21A2 TNXA TNXB	3.53e-07	4	156	3	12121677
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	SPNS1 VRK2 MYO1C ERO1A CNTNAP1 PSMB4 TUBB GPRC5A RFC1 ADAR VANGL1 EIF4A1 IFI30 SERPINB1 TMX3 YTHDF3 ALG1 ALPP ATP5F1C DCAF7	1.59e-06	1297	156	20	33545068
Pubmed	Developmental waves of mechanosensitivity acquisition in sensory neuron subtypes during embryonic development.	TRPV1 TRPC3 PKD1L3 SCNN1B TRPM1	1.61e-06	44	156	5	19322198
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SUPT20H MYO1C BPIFB1 INO80 TTC7A TBC1D10B SULF2 WIZ SH3TC1 VANGL1 DPF3 AHR TMX3 KAT6B TOP2A TENT2 SEZ6L DCAF7	2.96e-06	1116	156	18	31753913
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	AKAP6 INO80 SULF2 NBEAL2 NCAPD2 PLEKHA5 FTO TMX3 MED23 KAT6B ESPL1 OGA	5.25e-06	529	156	12	14621295
Pubmed	ADAR1 mediated regulation of neural crest derived melanocytes and Schwann cell development.	DUSP15 RET ADAR TRPM1 PLXNA2	7.01e-06	59	156	5	31924792
Pubmed	A quantitative analysis of the spatiotemporal pattern of transient receptor potential gene expression in the developing mouse cochlea.	TRPV1 TRPC3 PKD1L3 TRPM1	1.44e-05	33	156	4	19834762
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	COL8A1 TGM2 HMCN1 SERPINB1 COL14A1 TNXB PLXNA2	1.50e-05	175	156	7	28071719
Pubmed	YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis.	CYP21A2 RET TNXB	1.89e-05	12	156	3	10101119
Pubmed	Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity.	ANKK1 FTO	2.00e-05	2	156	2	27600277
Pubmed	Lymphotoxin α1β2 expression on B cells is required for follicular dendritic cell activation during the germinal center response.	CD19 LTB	2.00e-05	2	156	2	23112125
Pubmed	A transient receptor potential-like channel mediates synaptic transmission in rod bipolar cells.	TRPV1 TRPM1	2.00e-05	2	156	2	19439586
Pubmed	Expression of lymphotoxin beta governs immunity at two distinct levels.	CD19 LTB	2.00e-05	2	156	2	16841297
Pubmed	The Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients.	RET ROS1	2.00e-05	2	156	2	25905642
Pubmed	ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells.	ERO1A MUC16	2.00e-05	2	156	2	33056994
Pubmed	Genetic variation in salt taste receptors impact salt intake and blood pressure.	TRPV1 SCNN1B	2.00e-05	2	156	2	36899055
Pubmed	ADAR1 silencing-induced HUVEC apoptosis is mediated by FGFR2 under hypoxia stress.	ADAR FGFR2	2.00e-05	2	156	2	30573948
Pubmed	Association of type 2 diabetes susceptible genes GCKR, SLC30A8, and FTO polymorphisms with gestational diabetes mellitus risk: a meta-analysis.	GCKR FTO	2.00e-05	2	156	2	30091126
Pubmed	Expression of sucrase-isomaltase and dipeptidylpeptidase IV in human small intestine and colon.	DPP4 SI	2.00e-05	2	156	2	1677636
Pubmed	The capsaicin receptor participates in artificial sweetener aversion.	TRPV1 TAS1R3	2.00e-05	2	156	2	18804451
Pubmed	Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting.	CD19 LTB	2.00e-05	2	156	2	12969314
Pubmed	Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus.	TNXA TNXB	2.00e-05	2	156	2	1373808
Pubmed	Sequences promoting the transcription of the human XA gene overlapping P450c21A correctly predict the presence of a novel, adrenal-specific, truncated form of tenascin-X.	TNXA TNXB	2.00e-05	2	156	2	8530023
Pubmed	Congenital adrenal hyperplasia with a CYP21A2 deletion overlapping the tenascin-X gene: an atypical presentation.	CYP21A2 TNXB	2.00e-05	2	156	2	36259452
Pubmed	From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?	RET ROS1	2.00e-05	2	156	2	26424208
Pubmed	SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation.	PIAS4 TGM2	2.00e-05	2	156	2	19625650
Pubmed	Fundamental Contribution and Host Range Determination of ANP32A and ANP32B in Influenza A Virus Polymerase Activity.	ANP32B ANP32A	2.00e-05	2	156	2	30996088
Pubmed	Species specific differences in use of ANP32 proteins by influenza A virus.	ANP32B ANP32A	2.00e-05	2	156	2	31159925
Pubmed	Mapping of a de novo unequal crossover causing a deletion of the steroid 21-hydroxylase (CYP21A2) gene and a non-functional hybrid tenascin-X (TNXB) gene.	CYP21A2 TNXB	2.00e-05	2	156	2	12746407
Pubmed	Ehlers-Danlos Syndrome Caused by Biallelic TNXB Variants in Patients with Congenital Adrenal Hyperplasia.	CYP21A2 TNXB	2.00e-05	2	156	2	27297501
Pubmed	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	ERO1A CYP21A2 SRMS ADAR MMP8 TNXA TNXB	3.65e-05	201	156	7	23535732
Pubmed	The protein tyrosine kinase family of the human genome.	SRMS RET ZAP70 ROS1 FGFR2	3.73e-05	83	156	5	11114734
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	RGPD4 TUBB WIZ FGFR2 TOP2A	4.42e-05	86	156	5	37253089
Pubmed	Functional genomic landscape of cancer-intrinsic evasion of killing by T cells.	HSCB SUPT20H ATG7 PELI1 CTR9 NCAPD2 MED25 MED23 ALG1 WIPI2	4.43e-05	457	156	10	32968282
Pubmed	Mitochondrial Raf1 Regulates Glutamine Catabolism.	ARHGAP32 TUBB GPRC5A ADAR CIT EIF4A1 SERPINB1 ATP5F1C	5.05e-05	288	156	8	38496616
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	SUPT20H ATG7 ANP32B PSMB4 INO80 RFC1 ADAR CTR9 EIF4A1 ANP32A NCAPD2 MED25 MED23 TOP2A DCAF7	5.56e-05	1014	156	15	32416067
Pubmed	ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare.	RET ROS1	5.98e-05	3	156	2	26973202
Pubmed	ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features.	RET ROS1	5.98e-05	3	156	2	24629636
Pubmed	Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus.	TNXA TNXB	5.98e-05	3	156	2	2475872
Pubmed	Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma.	ZAP70 CD19	5.98e-05	3	156	2	27748274
Pubmed	m6A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7.	ATG7 FTO	5.98e-05	3	156	2	31451060
Pubmed	Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.	RET ROS1	5.98e-05	3	156	2	25723109
Pubmed	Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues.	CD19 LTB	5.98e-05	3	156	2	12354378
Pubmed	Two novel genes, Gpr113, which encodes a family 2 G-protein-coupled receptor, and Trcg1, are selectively expressed in taste receptor cells.	TAS1R3 ADGRF3	5.98e-05	3	156	2	15780750
Pubmed	Development of lung adenocarcinomas with exclusive dependence on oncogene fusions.	RET ROS1	5.98e-05	3	156	2	25855381
Pubmed	KPNA6 is a Cofactor of ANP32A/B in Supporting Influenza Virus Polymerase Activity.	ANP32B ANP32A	5.98e-05	3	156	2	35044222
Pubmed	Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway.	ANP32B ANP32A	5.98e-05	3	156	2	12522243
Pubmed	Core2 O-glycan structure is essential for the cell surface expression of sucrase isomaltase and dipeptidyl peptidase-IV during intestinal cell differentiation.	DPP4 SI	5.98e-05	3	156	2	20841351
Pubmed	Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers.	RET ROS1	5.98e-05	3	156	2	34310819
Pubmed	Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers.	RET ROS1	5.98e-05	3	156	2	27056998
Pubmed	Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation--opposite functions for surface lymphotoxin expressed by T and B lymphocytes.	CD19 LTB	5.98e-05	3	156	2	17590442
Pubmed	Potential Unreliability of Uncommon ALK, ROS1, and RET Genomic Breakpoints in Predicting the Efficacy of Targeted Therapy in NSCLC.	RET ROS1	5.98e-05	3	156	2	33248323
Pubmed	Essential role for autophagy in the maintenance of immunological memory against influenza infection.	ATG7 CD19	5.98e-05	3	156	2	24747745
Pubmed	DNA topoisomerases participate in fragility of the oncogene RET.	RET TOP2A	5.98e-05	3	156	2	24040417
Pubmed	Innate lymphoid cells facilitate NK cell development through a lymphotoxin-mediated stromal microenvironment.	CD19 LTB	5.98e-05	3	156	2	24913234
Pubmed	A novel form of capsaicin-modified amygdala LTD mediated by TRPM1.	TRPV1 TRPM1	5.98e-05	3	156	2	27633915
Pubmed	Molecular motor MYO1C, acetyltransferase KAT6B and osteogenetic transcription factor RUNX2 expression in human masseter muscle contributes to development of malocclusion.	MYO1C KAT6B	5.98e-05	3	156	2	24698832
Pubmed	The E3 ubiquitin ligase Peli1 regulates the metabolic actions of mTORC1 to suppress antitumor T cell responses.	PELI1 CD19	5.98e-05	3	156	2	33215753
Pubmed	Comprehensive analysis of ALK, ROS1 and RET rearrangements in locally advanced rectal cancer.	RET ROS1	5.98e-05	3	156	2	33168793
Pubmed	High incidence of vesicoureteral reflux in mice with Fgfr2 deletion in kidney mesenchyma.	RET FGFR2	5.98e-05	3	156	2	20303521
Pubmed	ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer.	SLC38A4 ADAR	5.98e-05	3	156	2	36599932
Pubmed	Sensory attributes of complex tasting divalent salts are mediated by TRPM5 and TRPV1 channels.	TRPV1 TAS1R3	5.98e-05	3	156	2	19244541
Pubmed	RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors.	RET GAB1	5.98e-05	3	156	2	15940252
Pubmed	Clinicopathological characteristics and survival of ALK, ROS1 and RET rearrangements in non-adenocarcinoma non-small cell lung cancer patients.	RET ROS1	5.98e-05	3	156	2	27635639
Pubmed	Genetic basis of tobacco smoking: strong association of a specific major histocompatibility complex haplotype on chromosome 6 with smoking behavior.	TNXA TNXB	5.98e-05	3	156	2	15339882
Pubmed	Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer.	RET ROS1	5.98e-05	3	156	2	28181564
Pubmed	Kinase gene fusions in defined subsets of melanoma.	RET ROS1	5.98e-05	3	156	2	27864876
Pubmed	ANP32A and ANP32B are key factors in the Rev-dependent CRM1 pathway for nuclear export of HIV-1 unspliced mRNA.	ANP32B ANP32A	5.98e-05	3	156	2	31444273
Pubmed	Biochemical and biological responses induced by coupling of Gab1 to phosphatidylinositol 3-kinase in RET-expressing cells.	RET GAB1	5.98e-05	3	156	2	15351743
Pubmed	Autophagy is required for ectoplasmic specialization assembly in sertoli cells.	ATG7 PLEKHA5	5.98e-05	3	156	2	26986811
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	AKAP6 TTC7A NLN SULF2 PLEKHA5 KAT6B OGA	7.44e-05	225	156	7	12168954
Pubmed	Uncoupling of molecular maturation from peripheral target innervation in nociceptors expressing a chimeric TrkA/TrkC receptor.	TRPV1 TRPC3 RET	8.14e-05	19	156	3	24516396
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	COL8A1 CPQ SERPINB1 COL14A1 TNXB	9.53e-05	101	156	5	20551380
Pubmed	The repertoire of solute carriers of family 6: identification of new human and rodent genes.	SLC6A15 SLC6A6 SLC6A11	1.11e-04	21	156	3	16125675
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	RGPD4 COL8A1 MYO1C TUBB MUC16 TGM2 HMCN1 EIF4A1 SERPINB1 HAL TOP2A YTHDF3 ATP5F1C	1.19e-04	844	156	13	25963833
Pubmed	Loss of H3K27me3 imprinting in the Sfmbt2 miRNA cluster causes enlargement of cloned mouse placentas.	SLC38A4 GAB1	1.19e-04	4	156	2	32358519
Pubmed	Trpm1: Novel function at the intersection of light and pain response in the iris.	TRPV1 TRPM1	1.19e-04	4	156	2	34954202
Pubmed	Variant mapping and mutation discovery in inbred mice using next-generation sequencing.	ADAR CLCN1	1.19e-04	4	156	2	26552429
Pubmed	Hypotaurine Is a Substrate of GABA Transporter Family Members GAT2/Slc6a13 and TAUT/Slc6a6.	SLC6A6 SLC6A11	1.19e-04	4	156	2	30270321
Pubmed	B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity.	CD19 LTB	1.19e-04	4	156	2	22386268
Pubmed	Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease associations.	CYP21A2 TNXB	1.19e-04	4	156	2	10207042
Pubmed	Pulsatile atheroprone shear stress affects the expression of transient receptor potential channels in human endothelial cells.	TRPV1 TRPC3	1.19e-04	4	156	2	22566504
Pubmed	The Pellino1-PKCθ Signaling Axis Is an Essential Target for Improving Antitumor CD8+ T-lymphocyte Function.	PELI1 ZAP70	1.19e-04	4	156	2	35058288
Pubmed	Expression regulation and function of heparan sulfate 6-O-endosulfatases in the spermatogonial stem cell niche.	RET SULF2	1.19e-04	4	156	2	20855470
Pubmed	Detection of Gene Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell Lung Cancer and ERG-Rearrangements in Prostate Cancer.	RET ROS1	1.19e-04	4	156	2	28560674
Pubmed	Protein ligands to HuR modulate its interaction with target mRNAs in vivo.	ANP32B ANP32A	1.19e-04	4	156	2	11018049
Pubmed	Structural analysis of mouse tenascin-X: evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family.	CYP21A2 TNXB	1.19e-04	4	156	2	9795100
Pubmed	Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction.	RET GAB1	1.19e-04	4	156	2	11360177
Pubmed	ANP32B Deficiency Protects Mice From Lethal Influenza A Virus Challenge by Dampening the Host Immune Response.	ANP32B ANP32A	1.19e-04	4	156	2	32231671
Pubmed	Mammalian ANP32A and ANP32B Proteins Drive Differential Polymerase Adaptations in Avian Influenza Virus.	ANP32B ANP32A	1.19e-04	4	156	2	37074204
Pubmed	Delineation of mRNA export pathways by the use of cell-permeable peptides.	ANP32B ANP32A	1.19e-04	4	156	2	11729309
Pubmed	Prothymosin α interacts with SET, ANP32A and ANP32B and other cytoplasmic and mitochondrial proteins in proliferating cells.	ANP32B ANP32A	1.19e-04	4	156	2	29106904
Pubmed	Mosaic analysis of cell rearrangements during ureteric bud branching in dissociated/reaggregated kidney cultures and in vivo.	RET FGFR2	1.19e-04	4	156	2	26813041
Pubmed	Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection.	CD19 LTB	1.19e-04	4	156	2	25673724
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	ADAMTS4 TUBB DNAH2 SRMS PELI1 PIAS4 TGM2 EIF4A1 KCTD2 MMP8 KAT6B ALG1	1.20e-04	730	156	12	34857952
Pubmed	Human gingiva transcriptome during wound healing.	ADAMTS4 TGM2 SERPINB1 ANKFN1 RCAN2	1.25e-04	107	156	5	28005267
Pubmed	Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.	MYO1C PSMB4 TUBB RFC1 ADAR EIF4A1 TOP2A ATP5F1C	1.38e-04	333	156	8	36779763
Pubmed	Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain.	TRPV1 TRPC3 RET	1.47e-04	23	156	3	16446141
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	VRK2 MYO1C ANP32B TUBB RFC1 ADAR PIAS4 CTR9 FRG1 EIF4A1 ANP32A TOP2A ATP5F1C DCAF7	1.57e-04	989	156	14	36424410
GeneFamily	ANP32 acidic nuclear phosphoproteins	ANP32B ANP32A	4.17e-04	5	118	2	27
GeneFamily	Fibronectin type III domain containing	IGSF22 PTPRD COL14A1 ROS1 ANKFN1 TNXB	6.37e-04	160	118	6	555
GeneFamily	Transient receptor potential cation channels	TRPV1 TRPC3 TRPM1	7.88e-04	28	118	3	249
GeneFamily	Myosins, class I	MYO1C MYO1H	1.15e-03	8	118	2	1097
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	RET ROS1 FGFR2	2.25e-03	40	118	3	321
CoexpressionAtlas	cervix, uterine	CHST6 MUC16 BPIFB1 TGM2 SCNN1B COL14A1 ANKFN1 ALPP	1.16e-05	149	151	8	cervix, uterine
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NKX6-2 ADAMTS4 SLC6A15 CDH19 PTPRD FGFR2 CALN1 RCAN2	3.98e-07	193	155	8	947200ef6c3a2e35ad7e6b4af29d92384bdf73f5
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AKAP6 NKX6-2 ADAMTS4 CHADL CDH19 PTPRD FGFR2 RCAN2	4.14e-07	194	155	8	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC16 PKD1L3 RYR3 PTPRD HMCN1 COL14A1 MMP8 CALN1	4.30e-07	195	155	8	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC16 PKD1L3 RYR3 PTPRD HMCN1 COL14A1 MMP8 CALN1	4.30e-07	195	155	8	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	390C-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	DPP4 CHADL PLEKHA5 MPND FTO PLXNA2 RCAN2	2.35e-06	171	155	7	70963f79711fe6088d6d01b29206b17ab89e5e73
ToppCell	LPS_only-Unknown-Endothelial-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRPV1 TRPC3 PYROXD2 CDH19 IGSF22 DPF3	3.13e-06	115	155	6	c67145d3cd9243994a141749b426ff2a6dcc8d93
ToppCell	LPS_only-Unknown-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRPV1 TRPC3 PYROXD2 CDH19 IGSF22 DPF3	3.13e-06	115	155	6	ad5298c2ad8bf94fa13c2e50b0799e929473ef59
ToppCell	LPS_only-Unknown\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRPV1 TRPC3 PYROXD2 CDH19 IGSF22 DPF3	3.13e-06	115	155	6	7a733f6987b40ec497a03734b79ed5355ad3a2fc
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	GPRC5A CIT PTPRD SCNN1B SERPINB1 ROS1 FGFR2	3.42e-06	181	155	7	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX6-2 ADAMTS4 PLA2G3 DUSP15 SERPINB1 FGFR2 RCAN2	3.95e-06	185	155	7	7406a9fdd5beb2777a9cad3268673977bb19f050
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AKAP6 NKX6-2 SLC6A15 GPRC5A CDH19 SLC6A6 RCAN2	4.39e-06	188	155	7	6c7ce6e28e4433092605880acf127833e7b66ebe
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	ARMC3 TTLL9 DNAH2 CHST6 MUC16 RYR3 C11orf97	4.87e-06	191	155	7	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	ARMC3 TTLL9 DNAH2 CHST6 MUC16 RYR3 C11orf97	4.87e-06	191	155	7	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPP4 NAALAD2 RET SULF2 CPQ COL14A1 TNXB	5.04e-06	192	155	7	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	IPF-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	GPRC5A PTPRD HMCN1 SCNN1B AHR ROS1 FGFR2	5.04e-06	192	155	7	356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX6-2 ADAMTS4 SULF2 PTPRD JOSD2 SERPINB1 FGFR2	5.77e-06	196	155	7	f068ce40bf35021baf1468ae9ce30a92162eb14d
ToppCell	AT2_cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	DPP4 COL8A1 GPRC5A HMCN1 SCNN1B ROS1 RCAN2	5.97e-06	197	155	7	5e0d222872a25bb9e9069d3dffda2844bb69874a
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NKX6-2 ADAMTS4 CHADL CDH19 SLC6A6 PTPRD FGFR2	5.97e-06	197	155	7	82b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX6-2 ADAMTS4 PTPRD JOSD2 SERPINB1 FGFR2 RCAN2	6.17e-06	198	155	7	97ae237f955fd5fbd01d06aafe89ef9e6f777a9a
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX6-2 ADAMTS4 SULF2 PTPRD JOSD2 FGFR2 GAB1	6.59e-06	200	155	7	56f1f007ba8c9188a4b10e52744f1e50dc0f155a
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NKX6-2 ADAMTS4 CHADL CDH19 PTPRD FGFR2 RCAN2	6.59e-06	200	155	7	3ce8a2db8c25e1169a0a544f644a63104749c5ee
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NKX6-2 ADAMTS4 CDH19 SERPINB1 FGFR2 GAB1	8.60e-06	137	155	6	b03f19b233c1c809f2cd2b4a7642eeaf254a6289
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NKX6-2 ADAMTS4 CDH19 SERPINB1 FGFR2 GAB1	8.60e-06	137	155	6	ca8fdbe66a854e6283b22179ec9359ea9e86cd8e
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1\|Cerebellum / BrainAtlas - Mouse McCarroll V32	DPP4 GIMAP5 SRMS ZAP70 CCM2L HMCN1	1.19e-05	145	155	6	37580218f6a6f65a1d827cbcf59465f8827f9a55
ToppCell	Ciliated_cells-B-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	NKX6-2 ARMC3 TTLL9 DNAH2 BEND2 C11orf97	1.39e-05	149	155	6	6399c5a2f06d79f020dece252526f1c0c110d569
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NKX6-2 ADAMTS4 CDH19 SERPINB1 FGFR2 GAB1	1.44e-05	150	155	6	b30f52b94ce772632a1f2f5e0837db876cf92651
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NKX6-2 ADAMTS4 CDH19 SERPINB1 FGFR2 GAB1	1.44e-05	150	155	6	05b9a9cbc5a95cdaf45d5f173e132acd4da9aa8a
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO1H MUC16 BPIFB1 GAL3ST2 FGFR2 ESPL1	2.01e-05	159	155	6	60b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCell	Entopeduncular\|World / BrainAtlas - Mouse McCarroll V32	NKX6-2 ADAMTS4 JOSD2 SERPINB1 FGFR2 GAB1	2.08e-05	160	155	6	833763c8608de4ee6003b8fb682aa9c83d7dea9b
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	OBP2A MUC16 BPIFB1 SCNN1B AHR FGFR2	2.15e-05	161	155	6	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	Influenza_Severe-B_memory\|World / Disease group and Cell class	ANKK1 MYO1C MUC16 CD19 DPF3 LTB	2.23e-05	162	155	6	21eb96cd4fecd85dd6acbbc3760944fa1a7cff42
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK\|Cerebellum / BrainAtlas - Mouse McCarroll V32	DPP4 GIMAP5 SRMS ZAP70 CCM2L HMCN1	2.47e-05	165	155	6	7d319a112b9062efee428bef6f4534d2ce782e04
ToppCell	3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LANCL3 PLA2G3 RET SCNN1B ESPL1 RCAN2	2.64e-05	167	155	6	7ec032a98a13504d15c7e3a4e259278d07f40180
ToppCell	3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LANCL3 PLA2G3 RET SCNN1B ESPL1 RCAN2	2.64e-05	167	155	6	49d9220f22d10ff06c0512c9c40c26ad51728e4f
ToppCell	3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LANCL3 PLA2G3 RET SCNN1B ESPL1 RCAN2	2.64e-05	167	155	6	5e3588eee73693a996bb4846427cf0038ceafbca
ToppCell	droplet-Thymus-nan-21m-Myeloid-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARMC3 CNTNAP1 CD19 IFI30 SERPINB1 LTB	2.73e-05	168	155	6	69dd747be46e7fbcec571cddd6dee374b9c2507a
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CIT NCAPD2 HAL ARHGEF37 MMP8 TOP2A	3.02e-05	171	155	6	6e7ade1d14a3ec4c566476aac3eb509bd2661e39
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TUBB GCKR CIT NCAPD2 ESPL1 TOP2A	3.02e-05	171	155	6	621f9da0bfa09c86fc89fd26919403e94cd56d2b
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP5 ZAP70 CD19 IFI30 LTB TNXB	3.12e-05	172	155	6	e04b1788f2074e66dff00cac734c8ee2cfefca6e
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AKAP6 SLC25A34 TUBB NCAPD2 TOP2A RCAN2	3.33e-05	174	155	6	41eb0a214a8b4015a26311f77061c8147144f0e7
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AKAP6 ARMC3 TTLL9 IFT172 MUC16 BPIFB1	3.55e-05	176	155	6	dee780cfa85234a7cd7bf440b66b84cec959893e
ToppCell	severe-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PELI1 SLC6A6 SULF2 CPQ HAL SEC14L1	3.66e-05	177	155	6	d1ad35ee3d2a84b1d01126d0a38464ab858c00d0
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AKAP6 ANKK1 ARMC3 TTLL9 DNAH2 CHST6	3.78e-05	178	155	6	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CNTNAP1 MUC16 COL14A1 HAL TNXB TOP2A	3.78e-05	178	155	6	c77a1d1a9aef0ab51b4408b9e84f201219788ca2
ToppCell	Ciliated_cells-A-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	ARMC3 DNAH2 CHST6 MUC16 BPIFB1 C11orf97	4.02e-05	180	155	6	d9be152773fe9f2160edad9246fa03c03afeafd6
ToppCell	droplet-Lung-nan-18m-Lymphocytic-Ly6g5b+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1A DUSP15 RET ZAP70 SERPINB1 LTB	4.02e-05	180	155	6	81c7086399256260e59424b7410feec514ce8027
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYB5RL SLC38A4 CCM2L HMCN1 SCNN1B TNXB	4.02e-05	180	155	6	25f8e82bbc1853cb7d072484e99369c72779dd1e
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-Ly6g5b+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1A RET ZAP70 NBEAL2 SERPINB1 LTB	4.02e-05	180	155	6	5c649e2b3f5a53c0040b69df6e289fb3427ef2db
ToppCell	AT1_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	COL8A1 MYO1C GPRC5A NBEAL2 SCNN1B ALPP	4.02e-05	180	155	6	2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2
ToppCell	Thalamus-Macroglia\|Thalamus / BrainAtlas - Mouse McCarroll V32	NKX6-2 ADAMTS4 CDH19 JOSD2 FGFR2 GAB1	4.15e-05	181	155	6	4f62b63854a4e9fea6e839f0340e78392c66fb0e
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX6-2 PLA2G3 DUSP15 SERPINB1 FGFR2 RCAN2	4.15e-05	181	155	6	6d80795f96aac11fec1c946d1f2d16cfe6e38d9a
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX6-2 PLA2G3 DUSP15 SERPINB1 FGFR2 RCAN2	4.15e-05	181	155	6	04c278ad22e32a4f75af92fc9bfe439363c04f90
ToppCell	COVID-19_Mild-CD4+_T_activated\|COVID-19_Mild / Disease condition and Cell class	GIMAP5 ERO1A LTB OGA TENT2 ATP5F1C	4.28e-05	182	155	6	877b6e611626628e709568747512f2827ebb2795
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AKAP6 CDH19 ARHGEF37 ESPL1 GAB1 RCAN2	4.28e-05	182	155	6	a1c0e4090a9e7aa4941a40c817d178de144888b6
ToppCell	severe-Myeloid-Neutrophils_1\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PELI1 SLC6A6 SULF2 CPQ HAL SEC14L1	4.41e-05	183	155	6	60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e
ToppCell	PND14\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GIMAP5 CCM2L HMCN1 CD19 SERPINB1 LTB	4.55e-05	184	155	6	1bfee4eb121e76a79f48b06b45f05d124fbbedba
ToppCell	mild-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PELI1 SLC6A6 CPQ MED25 LTB SEC14L1	4.55e-05	184	155	6	1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANP32B TUBB CD19 NCAPD2 IFI30 TOP2A	4.55e-05	184	155	6	8f40093de5bb978f046d66e8f05f333686a009a4
ToppCell	IPF-Epithelial-ATII\|IPF / Disease state, Lineage and Cell class	DPP4 COL8A1 GPRC5A AHR ROS1 FGFR2	4.69e-05	185	155	6	563b4e6d92bb5d77a3829556116a8e99aebac615
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	DPP4 COL8A1 GPRC5A AHR ROS1 FGFR2	4.83e-05	186	155	6	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	COPD-Epithelial-Club\|World / Disease state, Lineage and Cell class	GPRC5A PTPRD SCNN1B AHR ROS1 FGFR2	4.83e-05	186	155	6	3006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCell	Control-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	COL8A1 MYO1C GPRC5A NBEAL2 SCNN1B ALPP	4.97e-05	187	155	6	3a032432f780525f4f4c2a358897d9989b1ecae7
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Proliferating_Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANP32B TUBB NCAPD2 IFI30 MMP8 TOP2A	5.12e-05	188	155	6	a6ad6de6aeaf213952124252c1452b73942a0c3d
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	AKAP6 COL8A1 RYR3 CYP7B1 COL14A1 RCAN2	5.28e-05	189	155	6	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	IPF-Epithelial-Club\|IPF / Disease state, Lineage and Cell class	BPIFB1 GPRC5A SCNN1B AHR ROS1 FGFR2	5.28e-05	189	155	6	f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCell	droplet-Heart-nan-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 NAALAD2 SULF2 PLEKHA5 COL14A1 TNXB	5.43e-05	190	155	6	96a92212ea3fb35fa3d0da495e504edc61c71c23
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AKAP6 COL8A1 TRPC3 HMCN1 COL14A1 RCAN2	5.43e-05	190	155	6	562ee3b025c29edf07b8b344323edb49d82f1c7e
ToppCell	facs-Trachea-24m-Hematologic-lymphocytic\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GIMAP5 RET ZAP70 CD19 SERPINB1 LTB	5.43e-05	190	155	6	10f7d33fd1ff096f8fe5b7b11a58819d6cc14fbc
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AKAP6 COL8A1 TRPC3 HMCN1 COL14A1 RCAN2	5.43e-05	190	155	6	f5fb989afabb49d64d91324570cd8c80a4b9e67d
ToppCell	COPD-Epithelial-Club\|COPD / Disease state, Lineage and Cell class	GPRC5A PTPRD SCNN1B AHR ROS1 FGFR2	5.59e-05	191	155	6	c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL8A1 NAALAD2 CNTNAP1 CPQ COL14A1 TNXB	5.59e-05	191	155	6	b51e0f5d1b93f526160c904e9091313a5364f3a7
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	BPIFB1 GPRC5A SCNN1B AHR ROS1 FGFR2	5.59e-05	191	155	6	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ARMC3 DNAH2 CHST6 MUC16 C11orf97 ANKFN1	5.59e-05	191	155	6	e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a
ToppCell	control-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PELI1 SLC6A6 CPQ MED25 LTB SEC14L1	5.59e-05	191	155	6	db1b3cd07d7d190155b2d14e82e1d124975fbd0b
ToppCell	LAM-Epithelial-AT1\|Epithelial / Condition, Lineage and Cell class	COL8A1 MYO1C GPRC5A NBEAL2 SCNN1B ALPP	5.59e-05	191	155	6	3457e15d1e9b36a78363d46b320c4ec46b40290a
ToppCell	wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DPP4 GIMAP5 SLC38A4 SULF2 SCNN1B TNXB	5.59e-05	191	155	6	d25ac3206fe205a100cfee26431ff32c14c1938f
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPP4 NAALAD2 PTPRD CPQ PLEKHA5 TNXB	5.76e-05	192	155	6	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	15-Trachea-Epithelial-Intermediate_ciliated\|Trachea / Age, Tissue, Lineage and Cell class	ARHGAP32 ARMC3 IFT172 DNAH2 MUC16 C11orf97	5.76e-05	192	155	6	9cbe961a800c981cdc742a47ed18e9c8eb6430bd
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX6-2 PTPRD JOSD2 SERPINB1 FGFR2 RCAN2	5.76e-05	192	155	6	3916de42b9a626b5679ca98057d6e69f146b2810
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DPP4 TAS1R3 GPRC5A LHX9 ROS1 TOP2A	5.93e-05	193	155	6	44839a606ae2f8e37421bda46d588189e1c943d2
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX6-2 DUSP15 PTPRD JOSD2 SERPINB1 FGFR2	5.93e-05	193	155	6	4274c95cedad2ae8c6693ad00deda2b1ba5b5682
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANP32B TUBB NCAPD2 IFI30 MMP8 TOP2A	5.93e-05	193	155	6	4a3e456f07e521519faeb9153e8d571cb8fbeaf9
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	GIMAP5 SRMS CCM2L HMCN1 SH3TC1	6.06e-05	119	155	5	a3807e738d7ca8cf80aa4bd35e3ee4357b1dc00f
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)--\|Hippocampus / BrainAtlas - Mouse McCarroll V32	GIMAP5 SRMS CCM2L HMCN1 SH3TC1	6.06e-05	119	155	5	8a3f0a3ed9f80d7b061162e9fa519bb09804a86c
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	GIMAP5 SRMS CCM2L HMCN1 SH3TC1	6.06e-05	119	155	5	938da0fe90372709048bf4e5503cc1cbf8376b17
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC29A3 GIMAP5 LCT IFI30 ADGRF3 LILRA4	6.10e-05	194	155	6	b829a63b51b92507a53ffd0393bd9458b2b9440f
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANP32B TUBB NCAPD2 IFI30 MMP8 TOP2A	6.10e-05	194	155	6	5810d8e1f6b983bb346fe06dda22b8ba3f2144a6
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL8A1 MYO1C GPRC5A NBEAL2 SCNN1B ALPP	6.27e-05	195	155	6	2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f
ToppCell	facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL8A1 NAALAD2 SULF2 CPQ COL14A1 TNXB	6.27e-05	195	155	6	690d6e15d7c863fc8f2d33b1f7bf86f019f415c9
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL8A1 MYO1C GPRC5A NBEAL2 SCNN1B ALPP	6.27e-05	195	155	6	68f4cc84b5ae7f4159b780c78e4b66c94211779a
ToppCell	AT1_cells\|World / lung cells shred on cell class, cell subclass, sample id	COL8A1 MYO1C GPRC5A NBEAL2 SCNN1B ALPP	6.27e-05	195	155	6	792d6a49b0a875a00569071183d195287a9925c5
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 MUC16 BPIFB1 GAL3ST2 SCNN1B FGFR2	6.27e-05	195	155	6	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL8A1 NAALAD2 SULF2 CPQ COL14A1 TNXB	6.27e-05	195	155	6	5c05e2bcea3d5d7ebe6325f7187ccf83301053d8
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHST6 MUC16 BPIFB1 TGM2 SCNN1B AHR	6.45e-05	196	155	6	b07db4a53ab9be9aad6fae5e45f9547db829d096
ToppCell	AT1\|World / shred by cell class for parenchyma	GPX2 GPRC5A NBEAL2 SCNN1B TOP2A ALPP	6.45e-05	196	155	6	2bc487f8a109a6961ebff111dec79c2227ea60ac
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL8A1 MYO1C GPRC5A NBEAL2 SCNN1B ALPP	6.45e-05	196	155	6	6731fef8c148b6681d6ed38afdf23c8213e0bbbe
ToppCell	Epithelial_cells-AT1_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	COL8A1 MYO1C GPRC5A NBEAL2 SCNN1B ALPP	6.45e-05	196	155	6	6c99d29162848161c1f166a032320f87a5d5a631
ToppCell	droplet-Marrow-BM-1m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPP4 ANP32B TUBB CD19 NCAPD2 TOP2A	6.45e-05	196	155	6	ef1482f83872af72a55b6c5b5a1491e6f7f44dd7
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL8A1 MYO1C GPRC5A NBEAL2 SCNN1B ALPP	6.45e-05	196	155	6	eb68f7954e7c2f86d05e740e95b6e74805a6053f
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL8A1 MYO1C GPRC5A NBEAL2 SCNN1B ALPP	6.45e-05	196	155	6	6856317cd0cdcb88fe54b4ae905d91e13495b1c4
Drug	lidocaine	SPNS1 RET LCT RYR3 PRKD3 CPQ SCNN1B ROS1 OGA	1.40e-06	160	153	9	CID000003676
Disease	histidine measurement	SLC38A4 CYP21A2 TRPC3 GCKR HAL	2.14e-05	66	149	5	EFO_0009769
Disease	Hyperpigmentation	SLC29A3 AHR	7.57e-05	3	149	2	C0162834
Disease	sunburn	TPCN2 ADAR AHR TRPM1 HAL	1.30e-04	96	149	5	EFO_0003958
Disease	urinary sodium to creatinine ratio	CYP21A2 GCKR	1.51e-04	4	149	2	EFO_0009883
Disease	urinary metabolite measurement	NAALAD2 ERO1A CYP21A2 PYROXD2 IREB2 CDH19 HAL	2.58e-04	245	149	7	EFO_0005116
Disease	urolithiasis	CYP21A2 GCKR FTO ALPP	2.95e-04	63	149	4	MONDO_0024647
Disease	L-arginine measurement	SLC38A4 CYP21A2 MED23	3.38e-04	27	149	3	EFO_0006524
Disease	cutaneous melanoma	TPCN2 GPRC5A AHR HAL FTO	3.81e-04	121	149	5	EFO_0000389
Disease	breast size	HSCB GCKR FTO KAT6B	4.18e-04	69	149	4	EFO_0004884
Disease	Congenital central hypoventilation	MYO1H RET	5.23e-04	7	149	2	C1275808
Disease	hypokalemic periodic paralysis (implicated_via_orthology)	TUBB SCNN1B	6.95e-04	8	149	2	DOID:14452 (implicated_via_orthology)
Disease	free cholesterol in large HDL measurement	MYO1H ETFDH GCKR SULF2	6.99e-04	79	149	4	EFO_0022157
Disease	Malignant neoplasm of liver	TTLL9 GPX2 SRMS AHR TOP2A	7.90e-04	142	149	5	C0345904
Disease	Liver neoplasms	TTLL9 GPX2 SRMS AHR TOP2A	7.90e-04	142	149	5	C0023903
Disease	irritability measurement	VRK2 MYO1H CHADL CDH19	8.05e-04	82	149	4	EFO_0009594
Disease	alcohol use disorder measurement, longitudinal alcohol consumption measurement	VRK2 GCKR FTO	8.64e-04	37	149	3	EFO_0007645, EFO_0009458
Disease	threonine measurement	SLC38A4 CYP21A2 GCKR	8.64e-04	37	149	3	EFO_0009775
Disease	attention deficit hyperactivity disorder, autism spectrum disorder, intelligence	AKAP6 DPP4 SPNS1 PELI1 PKD1L3 DPF3 OGA CALN1	9.75e-04	398	149	8	EFO_0003756, EFO_0003888, EFO_0004337
Disease	cystatin C measurement	TPCN2 CYP21A2 SRMS GCKR CCM2L AHR FTO RCAN2	1.04e-03	402	149	8	EFO_0004617
Disease	cholelithiasis	CYP21A2 GCKR ADAR FTO	1.05e-03	88	149	4	EFO_0004799
Disease	Metabolic Diseases	ETFDH AHR	1.11e-03	10	149	2	C0025517
Disease	abdominal aortic aneurysm (is_marker_for)	FTO MMP8	1.11e-03	10	149	2	DOID:7693 (is_marker_for)
Disease	ubiquitin-conjugating enzyme E2 G2 measurement	CYP21A2 TNXB	1.11e-03	10	149	2	EFO_0022035
Disease	sweet beverage consumption measurement	AHR FTO	1.11e-03	10	149	2	EFO_0010090
Disease	cancer antigen 125 measurement	MUC16 GAL3ST2	1.11e-03	10	149	2	EFO_0010603
Disease	Malignant neoplasm of breast	AKAP6 GPX2 ADAR TGM2 SULF2 CLCN1 PTPRD SCNN1B AHR FGFR2 FTO KAT6B TOP2A GAB1	1.12e-03	1074	149	14	C0006142
Disease	osteoarthritis, knee, body mass index	CYP21A2 PKD1L3 FTO	1.17e-03	41	149	3	EFO_0004340, EFO_0004616
Disease	chronic kidney disease	COL8A1 CYP21A2 ETFDH GCKR DPF3 FTO	1.28e-03	235	149	6	EFO_0003884
Disease	1-methylxanthine measurement	AHR CYP7B1	1.35e-03	11	149	2	EFO_0021174
Disease	quality of life during menstruation measurement, acne	NLN CALN1	1.35e-03	11	149	2	EFO_0003894, EFO_0009366
Disease	candidiasis (implicated_via_orthology)	ANP32B PRKD3 ANP32A	1.44e-03	44	149	3	DOID:1508 (implicated_via_orthology)
Disease	vital capacity	COL8A1 VRK2 MYO1C SLC6A15 INO80 PKD1L3 LCT PTPRD HMCN1 AHR FGFR2 ANKFN1 TNXB GAB1 DCAF7	1.52e-03	1236	149	15	EFO_0004312
Disease	alcohol consumption measurement	AKAP6 ANKK1 DPP4 VRK2 IFT172 CYP21A2 DNAH2 COX7A2 GPRC6A GCKR RFC1 PKD1L3 CIT FTO PLXNA2	1.60e-03	1242	149	15	EFO_0007878
Disease	vitamin D measurement	CYP21A2 PLA2G3 GCKR ADAR HAL FTO MED23	1.65e-03	336	149	7	EFO_0004631
Disease	Weight Gain	HDHD2 PRKD3 AHR FTO	1.81e-03	102	149	4	C0043094
Disease	superior frontal gyrus grey matter volume measurement	TBC1D19 COL8A1	2.21e-03	14	149	2	EFO_0006516
Disease	substance-related disorder	VRK2 GCKR FTO	2.33e-03	52	149	3	MONDO_0002494
Disease	glycerate measurement	RYR3 HMCN1	2.55e-03	15	149	2	EFO_0021029
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	CYP21A2 GCKR PKD1L3	2.88e-03	56	149	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	coffee consumption, cups of coffee per day measurement	GCKR AHR	2.90e-03	16	149	2	EFO_0004330, EFO_0006782
Disease	diacylglycerol 44:7 measurement	IFT172 GCKR	2.90e-03	16	149	2	EFO_0020069
Disease	fibrinogen measurement, factor VII measurement	CYP21A2 GCKR PKD1L3	3.18e-03	58	149	3	EFO_0004619, EFO_0004623
Disease	adverse effect, response to xenobiotic stimulus	CRYBB2 CYP7B1 COL14A1	3.34e-03	59	149	3	EFO_0009658, GO_0009410
Disease	insulin resistance	GCKR PTPRD SEZ6L	3.34e-03	59	149	3	EFO_0002614
Disease	age at first sexual intercourse measurement	AKAP6 VRK2 ARMC3 SLC6A15 PTPRD CPQ PLEKHA5	3.42e-03	383	149	7	EFO_0009749
Disease	androstenedione measurement, estrone measurement	ARMC3 PTPRD	3.67e-03	18	149	2	EFO_0007970, EFO_0007972
Disease	Adenocarcinoma of lung (disorder)	ANP32A AHR ROS1 FGFR2 TOP2A	4.01e-03	206	149	5	C0152013
Disease	neck circumference	FTO CALN1	4.09e-03	19	149	2	EFO_0011043
Disease	caffeine metabolite measurement	GCKR AHR	4.09e-03	19	149	2	EFO_0007872
Disease	choline measurement	MYO1H CYP21A2 GCKR SULF2	4.34e-03	130	149	4	EFO_0010116
Disease	sarcopenia	PTPRD FTO	4.53e-03	20	149	2	EFO_1000653
Disease	bitter alcoholic beverage consumption measurement	DNAH2 GCKR PTPRD PLXNA2	4.70e-03	133	149	4	EFO_0010092
Disease	alcohol use disorder measurement	ANKK1 DPP4 VRK2 GCKR FTO	4.71e-03	214	149	5	EFO_0009458
Disease	squamous cell carcinoma	TPCN2 AHR HAL	4.77e-03	67	149	3	EFO_0000707
Disease	cannabis dependence	DPP4 VRK2 PTPRD ANKFN1	4.96e-03	135	149	4	EFO_0007191
Disease	Hirschsprung disease	VRK2 RET	4.99e-03	21	149	2	MONDO_0018309
Disease	quinolinic acid measurement	CYP21A2 CDH19	4.99e-03	21	149	2	EFO_0010528
Disease	gestational age, birth measurement	SLC29A3 PTPRD	4.99e-03	21	149	2	EFO_0005112, EFO_0006921

Protein segments in the cluster

Peptide	Gene	Start	Entry
LERYLSAGPTLQYDK	VANGL1	441	Q8TAA9
YKQEPGAGLQLLTYI	TRAV5	56	A0A0B4J249
NARLLYKNGRPDYII	AHR	366	P35869
LEGSYRVYQLFPSKG	CATSPERG	541	Q6ZRH7
TLGLYLPQGQYLREG	ADGRF3	901	Q8IZF5
LRLGLYGCPYKADIL	CNTNAP1	161	P78357
YPGYRGLQYLLEKGD	CRYBB2	156	P43320
GKGPLREYYSRLIHQ	ALG1	321	Q9BT22
GVPGASLLDDLYKYF	CPQ	416	Q9Y646
YPAIKGDTIQLYLGA	BPIFB1	236	Q8TDL5
LLSRYGPGKLYQVTS	ARHGEF37	501	A1IGU5
YGPLHTAAARGKYLI	ANKK1	561	Q8NFD2
YYGGPESLLIKNNEI	BTBD11	981	A6QL63
NLGDLLLGFLKYYAT	TENT2	386	Q6PIY7
FKLLPQLTYLDGYDR	ANP32A	136	P39687
FKLLPQLTYLDGYDR	ANP32B	136	Q92688
GFYDYGRINPGTKLL	ARMC3	571	Q5W041
IPLYLKGGVADALLY	COX7A2	41	P14406
PIQDYCTGLLKLYGD	CCM2L	446	Q9NUG4
GLLYKGNYLNRSLSA	CALN1	51	Q9BXU9
YQPGGDLLSLLNRYE	CIT	176	O14578
KGVYPDLLATSGDYL	DCAF7	81	P61962
ALSGYDILQGYPKDI	MMP8	351	P22894
LNYDLLYAVAKLGPG	RCAN2	131	Q14206
PDGCRNGLKSKYYRL	GPRC5A	6	Q8NFJ5
GPYLLGVKAVLAESY	IREB2	861	P48200
SLATGYGAYLAQPLL	PSMB4	181	P28070
GGCTELAKPLYLQYL	INO80	11	Q9ULG1
LKDGPQYRVNYGSLD	KAT6B	166	Q8WYB5
EKPLSDLGRLSYLAY	KAT6B	891	Q8WYB5
ALKYQPIDSIRGYFG	ANO10	191	Q9NW15
YLQIKGATPRDSGLY	FGFR2	91	P21802
LGPYSLDKDSLYLNG	MUC16	14026	Q8WXI7
IRYTLYKEGADGLPQ	LILRA4	251	P59901
LILLGGNALSPKEFY	MAD2L1BP	151	Q15013
YYLVRNAQGTLTKGP	GREB1	191	Q4ZG55
DICGKRYKNRPGLSY	DPF3	201	Q92784
GRLTGDPDVLEYYKN	GAB1	36	Q13480
RILIGNPGCTYKYLN	FTO	96	Q9C0B1
ARYYKRKDGLALGPG	HDHD2	146	Q9H0R4
NILATYRPADKDYGL	PPP1R2P1	51	Q96PQ5
YYNLDSKLRAPEALG	JOSD2	136	Q8TAC2
YGYLGDPKRNVRVLK	BEND2	476	Q8NDZ0
IYLLGLTQKFGPIYR	CYP21A2	46	P08686
ESLLRGIYAYGFEKP	EIF4A1	41	P60842
EYRLLQAAYLAKPGD	PLXNA2	306	O75051
YTELAAKSGGLALPY	LHX9	201	Q9NQ69
LGGLYKFHDRPVTYL	MED23	991	Q9ULK4
YKPNQYGELLLLAAG	CYB5RL	176	Q6IPT4
GAPGIAYLFAKAYLV	LANCL3	296	Q6ZV70
AYLAPEVLRSKGYNR	PRKD3	741	O94806
LEYTRGKVPIYLAGN	LCT	741	P09848
ANLGPYFEGLRKHYL	MED25	26	Q71SY5
PGGRNLYKIQLSDYT	DPP4	426	P27487
KNLLYLGRDYPKGAD	ETFRF1	16	Q6IPR1
LEPGAGVLSIYYLGK	MPND	86	Q8N594
KDLGPAYSILGRYQT	ODF3	81	Q96PU9
SAYGGRKLIYLQELP	OBP2A	91	Q9NY56
LQGKSLYSYAGLAPR	ARHGAP32	1696	A7KAX9
NLLGKYTAEPYGELI	HMCN1	4211	Q96RW7
AQRPGLALNYYKEAG	IFT172	1226	Q9UG01
KPLYTYLIAGGDRSV	GCKR	131	Q14397
LYKNIGDCYLLSAPG	GIMAP5	96	Q96F15
NSTLLPGVKLGYEIY	GPRC6A	86	Q5T6X5
NRSSYRYDSLLLGPK	NPC1L1	416	Q9UHC9
TVLLYGNGPGYVLKD	ALPP	411	P05187
RIALKSGYGKYLGIN	FRG1	106	Q14331
PYQSGKADILGYNLR	GAL3ST2	341	Q9H3Q3
LGLVVGLDYQNPYLS	ETFDH	321	Q16134
YLALKLPDGSYALNG	ADAMTS4	726	O75173
RLKYLIGAAPIAYGL	ESPL1	2101	Q14674
GTEPLRIQYSLGKYD	IGSF22	271	Q8N9C0
GPQRQILDKSYYLGL	IFT74	86	Q96LB3
GEYPAKALDYLAIGI	HAL	446	P42357
LSALKGYLYAVGGRN	KLHL13	436	Q9P2N7
YYNGDSAGLPARLTL	ATG7	51	O95352
RYLNTNPVGGLLEYA	ADAR	721	P55265
VNYKTGNLYLRGPLK	IFI30	41	P13284
LLLPRATAQDAGKYY	CD19	246	P15391
GYLILYAPLTEGLAG	COL14A1	471	Q05707
LPGLYLGNFIDAKDL	DUSP15	6	Q9H1R2
GALAYYKKALRTNPG	CTR9	181	Q6PD62
SIRLIQAGAYYGIKP	COL8A1	21	P27658
LLLNPERYTGYKGPD	ERO1A	181	Q96HE7
ARIYGLGSLALYEKA	ATP5F1C	66	P36542
DDKPIGLNYSRLLFG	CYP7B1	476	O75881
GASYILKLANRLYGE	SERPINB1	81	P30740
AALEGAPRLGYLYLE	CHADL	491	Q6NUI6
EILNSLKYVRPGGGY	GPX2	81	P18283
NPKALSLGELYGEYD	DNAH2	2121	Q9P225
ADYIKRYLGDLTPLQ	SEC14L1	241	Q92503
YLLKGLHRLQKGPGY	SCNN1B	6	P51168
SYDYLNELGPRFKRL	CDH19	746	Q9H159
KYGELIVLGYNGSLP	PELI1	16	Q96FA3
RLQGLKPNSLYYFRL	PTPRD	571	P23468
TYFGPILNYLRHGKL	KCTD2	126	Q14681
DAYKTLLAPLSRGLY	HSCB	126	Q8IWL3
NGYLSTLALLYGPKI	SLC29A3	426	Q9BZD2
NYSEGDPLYKNGSLR	RGPD4	756	Q7Z3J3
CQKNGGGAYLLPYLI	SLC6A15	91	Q9H2J7
NGYQILYKRLYLPGE	SEZ6L	881	Q9BYH1
GAGIKFYLYPDITRL	SLC6A6	271	P31641
KAGGLIYQLDSYAPR	TRAPPC4	11	Q9Y296
ALYKGLGPAYLRLGP	SLC25A34	266	Q6PIV7
KYLAGPERARLAYSL	NKX6-2	171	Q9C056
YDQKRLFLGPYKGRS	OGA	286	O60502
AYRSYLNREGPKALG	RFC1	381	P35251
QVAAEGSGPLLYLLY	NBEAL2	1006	Q6ZNJ1
NHILLPSLYGDYRGK	PKD1L3	1336	Q7Z443
PSLYGDYRGKNAVLE	PKD1L3	1341	Q7Z443
LNAPGYKASFRGLYD	SH3TC1	506	Q8TE82
KIPRLLVGAADGYLY	WIPI2	341	Q9Y4P8
ASALLYQPYGAAVGL	WIZ	401	O95785
YLPADKIGLHLRGGY	SI	781	P14410
LPLSLLKNLGYLGYT	SLC38A4	211	Q969I6
DGSLYLQKGRLFPGL	SRMS	176	Q9H3Y6
GDPGLYLALLGRVYD	CYB5D2	51	Q8WUJ1
PLGYLSFLAKDAQGL	PLA2G3	41	Q9NZ20
PIQLRKGDFYSYLSL	AKAP6	2101	Q13023
RLFPGLYLGYLKLCS	ANKFN1	606	Q8N957
GALQLLGYRPVYSED	CHST6	351	Q9GZX3
AYRQLYLNPKGDSAR	NCAPD2	696	Q15021
LFDDIIYKILPGGYA	CLCN1	511	P35523
LLPQAKYYSRHGGLR	C11orf97	111	A0A1B0GVM6
VLGQFYLDLYPREGK	NLN	431	Q9BYT8
YNGILGPECGTKYLL	TGM2	516	P21980
KGDLAYNYRGPRTKD	TMX3	106	Q96JJ7
DQDYYLGGLRPDLRI	TRIM52	131	Q96A61
PRKEQGTYALSLIYG	ZAP70	191	P43403
AYRSLNGKGPLYLLF	YTHDF3	451	Q7Z739
KSDLLPGLRLGYDLF	TAS1R3	86	Q7RTX0
LLQVGYTPDGKDDYR	TRPV1	726	Q8NER1
LKAGRILGAQLPRYY	PYROXD2	206	Q8N2H3
YAIDNKYLPGLLRSG	RYR3	1591	Q15413
KYLPGLLRSGFYDLL	RYR3	1596	Q15413
LAPVFGYLGDRYNRK	SPNS1	111	Q9H2V7
KLTILQSLGDPLYYG	SUPT20H	351	Q8NEM7
QGLEPSRKYRFLLYG	TNXB	3411	P22105
YNEATGGKYVPRAIL	TUBB	51	P07437
ADRFYLGYPALGLLK	TM2D1	136	Q9BX74
GIKFYLYPDLSRLSD	SLC6A11	281	P48066
LPGYYSAGLEAIQLD	TBC1D10B	476	Q4KMP7
KNDYYRKRGEGLLPV	ROS1	2111	P08922
LYSLTLYGLRGPHKA	TNXA	216	Q16473
QDPGKGLRLIYYSVA	TRBV6-7	56	A0A0A0MS04
LYGKYLNGLGRLPAK	PIAS4	111	Q8N2W9
QDGPLLLIVEYAKYG	RET	796	P07949
RVLDIFGVNKYLGPY	TRPM1	941	Q7Z4N2
KLLGLPEDYLYGQTT	TOP2A	676	P11388
NPYLIGGRKFDLRVY	TTLL9	216	Q3SXZ7
LPKGYLALGLTYSLQ	TTC7A	486	Q9ULT0
LSQDEGRGTLYKYRP	PLEKHA5	616	Q9HAU0
PKSYIRGKLGLEEYA	TBC1D19	341	Q8N5T2
SRALSNLVPKYYGQG	SULF2	486	Q8IWU5
ERKQLDYLGIPLFYG	VRK2	91	Q86Y07
LKVFALGLRGYLSYP	TPCN2	486	Q8NHX9
SRINAYKGLASPAYL	TRPC3	201	Q13507
DAEGLALPQDGLYYL	LTB	121	Q06643
GLERNPQSYLYLVKG	MYO1C	256	O00159
PIGYNDAEILLRYLG	NAALAD2	286	Q9Y3Q0
RLSYLGLERDPQLYK	MYO1H	216	Q8N1T3
GLERDPQLYKYLSQG	MYO1H	221	Q8N1T3